Deadline: 16 Oct 2030
United Kingdom
Ref. No.: 20501640
EMD:Ref Document
Bid Value: Ref Document
1435 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501627
EMD:Ref Document
Bid Value: Ref Document
835 Days Left
Deadline: 29 Feb 2028
United Kingdom
Ref. No.: 20501615
EMD:Ref Document
Bid Value: Ref Document
475 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501603
EMD:Ref Document
Bid Value: Ref Document
835 Days Left
Deadline: 21 May 2027
United Kingdom
Ref. No.: 20501584
EMD:Ref Document
Bid Value: Ref Document
191 Days Left
Deadline: 01 Oct 2032
United Kingdom
Ref. No.: 20501566
EMD:Ref Document
Bid Value: Ref Document
2151 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501563
EMD:Ref Document
Bid Value: Ref Document
835 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20500236
EMD:Ref Document
Bid Value: Ref Document
293 Days Left
Deadline: 31 Dec 2031
Finland
Ref. No.: 20498561
EMD:Ref Document
Bid Value: Ref Document
1876 Days Left
Open House Pharmaceutical Discounts On The Active Ingredient Natalizumab S C Daring Form Atc L04Ag03
Deadline: 31 Aug 2027
Germany
Ref. No.: 20494511
EMD:Ref Document
Bid Value: Ref Document
293 Days Left
Deadline: 01 Sep 2033
France
Ref. No.: 20492591
EMD:Ref Document
Bid Value: Ref Document
2486 Days Left
Deadline: 12 Sep 2030
Bulgaria
Ref. No.: 20489067
EMD:Ref Document
Bid Value: Ref Document
1401 Days Left
Deadline: 03 Sep 2027
Germany
Ref. No.: 20487364
EMD:Ref Document
Bid Value: Ref Document
296 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20485097
EMD:Ref Document
Bid Value: Ref Document
293 Days Left
Spain
Ref. No.: 20484973
EMD:Ref Document
Bid Value: Ref Document
675 Days Left
